Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving medical devices and drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Legal woes, health risks lead to shrinking testosterone therapy market

November 15, 2017 - The prescription-only drugs were first approved by the Food and Drug Administration (FDA) as treatment to increase testosterone levels in men with hypogonadism. Read More


In risk-benefit calculation, are fears about Physiomesh valid?

November 8, 2017 - Physiomesh was designed and approved to repair and reinforce areas of weak muscle in the abdomen, called hernias. Read More


New York man awarded $1M in Risperdal gynecomastia lawsuit

November 1, 2017 - Risperdal has been linked to a condition called gynecomastia, in which males grow female-like breasts. Some plaintiffs developed breasts as large as DD and the breasts may even lactate. Read More


Taxotere may add misery of permanent hair loss to breast cancer patients’ plight

October 25, 2017 - Some breast cancer survivors have also been left with an enduring, physical reminder of their battle – permanent alopecia – thanks to the cancer drug Taxotere. Read More


First bellwether trial in Cook Medical IVC Filter MDL to begin next week

October 18, 2017 - IVC filters are used to catch blood clots before they reach vital organs such as the heart and lungs. These devices are used when blood thinners are not an option. Read More


Litigation alleges GSK profits off billions in Zofran sales, subjects parents to unnecessary loss

October 11, 2017 - The underlying claim is that Zofran causes birth defects in babies born to women who used the drug while pregnant. Read More


Jury awards $140 million to Plaintiff in testosterone replacement therapy litigation

October 5, 2017 - A jury in Illinois federal court awarded Plaintiff Jeffrey Konrad $140 million in litigation involving testosterone replacement therapy (TRT). Read More


Dietary changes provide better, safer alternative than PPIs in treating acid-related disorders

October 4, 2017 - Dietary intervention may have as much benefit as PPIs in reducing laryngopharyngeal reflux (LPR) – a condition that occurs in a person who has gastroesophageal reflux disease (GERD). Read More


Doctors abandoning Invokana over increased risk of amputations

September 27, 2017 - The latest reported adverse side effect connected to Invokana – an increased risk of amputation – has led some doctors to stop prescribing the diabetes drug. Read More


New, contradictory evidence from Xarelto makers could lead to retrial for plaintiff

September 21, 2017 - There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard during last month’s trial against Johnson & Johnson’s Janssen Pharmaceuticals and... Read More


back to top